Recently, Gu et al. 12 described an alternative therapeutic strategy to treat type 1 diabetes, namely, treatment by nanoparticles, which sustainably promotes the self-regulation of glucose-mediated insulin secretion. This evidence concerns the gene INS and type 1 diabetes mellitus.